Answers are grounded in this paper and cite their sources.
The rapid emergence of antimicrobial resistance and the increasing incidence of cancer have created an urgent need for novel therapeutic agents. In this study, mycosynthesized vanadium oxide nanoparticles (V2O3) were investigated for their antibacterial, antibiofilm, mechanistic, and anticancer activities. The nanoparticles demonstrated potent antibacterial activity against Staphylococcus aureus, including a multidrug-resistant clinical isolate, with a minimum inhibitory concentration (MIC) of 125 µg/mL. Furthermore, V2O3 NPs significantly disrupted preformed biofilms, achieving more than 80% biofilm reduction at the MIC. Mechanistic studies revealed that nanoparticle treatment induced concentration-dependent reactive oxygen species (ROS) generation, as confirmed by DPBF and TBARS assays, leading to enhanced lipid peroxidation and oxidative stress. Flow cytometric analysis using Annexin V-FITC/PI staining demonstrated apoptosis-like bacterial cell death, while scanning and transmission electron microscopy revealed severe membrane damage, cytoplasmic leakage, plasmolysis, and cellular collapse. In addition, VNPs exhibited significant cytotoxic activity against AGS human gastric cancer cells, with an IC50 of approximately 4 µg/mL and a pronounced concentration and time dependent inhibition of cell proliferation. In addition, DPPH and FRAP assay showed that VNPs have potential antioxidant activity. Collectively, these findings demonstrate that mycosynthesized VNPs exert antibacterial effects through oxidative damage and apoptosis-like death while simultaneously displaying potent anticancer activity. These multifunctional properties highlight their potential as promising agents for future biomedical applications. Key points • V2O3 nanoparticles strongly inhibited S. aureus and reduced biofilm. • Their antibacterial action involved ROS, lipid peroxidation, and membrane damage. • They also showed antioxidant activity and anticancer activity as reduced AGS gastric cancer cell growth. Graphical Abstract Graphical Abstract Mycosynthesized vanadium oxide nanoparticles (V2O3 NPs) were synthesized using Fusarium solani and characterized by UV–Vis spectroscopy, XRD, FESEM, TEM, and zeta potential analysis. The nanoparticles exhibited potent antibacterial activity against Staphylococcus aureus (MIC = 125 µg/mL) and effectively disrupted established biofilms. Mechanistic investigations demonstrated that V2O3 NPs induced dose- and time-dependent reactive oxygen species (ROS) generation, leading to lipid peroxidation, membrane damage, apoptosis-like bacterial cell death, and extensive ultrastructural disruption. In addition, the nanoparticles showed significant concentration- and time-dependent cytotoxic effects against AGS gastric cancer cells, the VNP showed potential antioxidant activity in free radical scavenging assay DPPH and iron reducing FRAP assay. Highlighting their potential as multifunctional nanomaterials for antimicrobial, anticancer, and antioxidant applications.
No takes yet. Share an insight, caveat, or question.
Mohammed et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: